Optimising outcomes for
patients with mCRPC:
A biomarker-guided approach
11:00 CEST, Tuesday, 12 May 2026
ADD TO CALENDAR17:00 CEST, Tuesday, 12 May 2026
It is with great pleasure that we invite you to attend this 60-minute webinar as part of the IMPaCT webinar series.
This webinar will explore recent advances in mCRPC, focusing on PARPi + ARPi combination therapies in the context of HRRm testing and biomarker‑driven treatment decision‑making. The clinical application of PARP inhibitors will be illustrated through a real‑world patient case, highlighting strategies to optimise outcomes, followed by a live Q&A with the expert faculty.
AGENDA
Topic
Welcome and introduction
Advancing patient care in mCRPC with PARPi + ARPi combination therapies
Why biomarkers matter: Integrating HRRm testing into routine practice
Real-world case study: Biomarker-guided treatment decisions with PARPi + ARPi beyond BRCA
m
Discussion and Q&A